Literature DB >> 16405456

G-Protein-coupled receptor-protein interactions: basis for new concepts on receptor structure and function.

Nanda Tilakaratne1, Patrick M Sexton.   

Abstract

1. G-Protein-coupled receptors (GPCRs) constitute a large family of cell surface proteins. Their primary function is to transmit extracellular stimuli to intracellular signals. It is estimated that the human genome contains more than 1000 genes that code for proteins of the GPCR structure. These receptors also comprise the most important class of therapeutic drug targets. 2. The mechanism of GPCR signalling was initially envisioned as involving coupling to the heterotrimeric G-proteins only. However, recent developments in the field suggest that such a simplistic model cannot be sustained any longer. The emerging view is that a wide range of accessory proteins are involved in the regulation of every aspect of GPCR activity. 3. G-Protein-coupled receptor-interacting proteins are implicated in the regulation of several aspects of GPCR biology, including receptor targeting to the respective sites of action, receptor anchoring, signalling and receptor desensitization. In some cases (e.g. receptor activity modifying proteins), they may contribute to the receptor structure and form a part of the ligand-binding domain. 4. These findings have contributed to new concepts of cellular organization in which modular protein-protein interactions provide a network through which signalling pathways are assembled and controlled.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16405456     DOI: 10.1111/j.1440-1681.2005.04295.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  9 in total

Review 1.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

2.  A new look at membrane protein binding.

Authors:  Charles A Lunn
Journal:  Nat Biotechnol       Date:  2011-04       Impact factor: 54.908

3.  The GPRC6A receptor displays constitutive internalization and sorting to the slow recycling pathway.

Authors:  Stine Engesgaard Jacobsen; Ina Ammendrup-Johnsen; Anna Mai Jansen; Ulrik Gether; Kenneth Lindegaard Madsen; Hans Bräuner-Osborne
Journal:  J Biol Chem       Date:  2017-03-09       Impact factor: 5.157

4.  A simple method for quantifying functional selectivity and agonist bias.

Authors:  Terry Kenakin; Christian Watson; Vanessa Muniz-Medina; Arthur Christopoulos; Steven Novick
Journal:  ACS Chem Neurosci       Date:  2011-12-20       Impact factor: 4.418

5.  Enhanced hypotensive, bradycardic, and hypnotic responses to alpha2-adrenergic agonists in spinophilin-null mice are accompanied by increased G protein coupling to the alpha2A-adrenergic receptor.

Authors:  R Lu; Y Chen; C Cottingham; N Peng; K Jiao; L E Limbird; J M Wyss; Q Wang
Journal:  Mol Pharmacol       Date:  2010-04-29       Impact factor: 4.436

6.  Opposite effects of PSD-95 and MPP3 PDZ proteins on serotonin 5-hydroxytryptamine2C receptor desensitization and membrane stability.

Authors:  Sophie Gavarini; Carine Bécamel; Christophe Altier; Philippe Lory; Joël Poncet; Jan Wijnholds; Joël Bockaert; Philippe Marin
Journal:  Mol Biol Cell       Date:  2006-08-16       Impact factor: 4.138

7.  The identification of novel proteins that interact with the GLP-1 receptor and restrain its activity.

Authors:  X Huang; F F Dai; G Gaisano; K Giglou; J Han; M Zhang; S Kittanakom; V Wong; L Wei; A D Showalter; K W Sloop; I Stagljar; M B Wheeler
Journal:  Mol Endocrinol       Date:  2013-07-17

8.  Modeling activated states of GPCRs: the rhodopsin template.

Authors:  Masha Y Niv; Lucy Skrabanek; Marta Filizola; Harel Weinstein
Journal:  J Comput Aided Mol Des       Date:  2006-11-11       Impact factor: 3.686

Review 9.  Modulation of opioid receptor function by protein-protein interactions.

Authors:  Konstantinos Alfaras-Melainis; Ivone Gomes; Raphael Rozenfeld; Venetia Zachariou; Lakshmi Devi
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.